Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

VIGOR++

Financiado

Cerrado

Virtual GastrOintestinal tRact

Inflammatory Bowel diseases (IBDs) constitute on of the largest healthcare problems in the Western World, affecting over 1 million European citizens alone, 700,000 of whom suffer from Crohn's disease.Grading of Crohn's disease sev... ver más

31/05/2014

TU Delft

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

TECHNISCHE UNIVERSITEIT DELFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-05-31 No tenemos la información de la convocatoria

0% 76% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

TU Delft

0.00€ | Lider

ZIB

N.D. | Participante

B3D

N.D. | Participante

ETH Zürich

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTC-2017-6564-1 SISTEMA ANALÍTICO AUTOMATIZADO BASADO EN BIOMARCADORES FECAL... 598K€ Cerrado

IBD-CHARACTER Inflammatory Bowel Disease CHARACTERization by a multi modal... 8M€ Cerrado

IBDetect Point of Care Diagnostic Test for the Differential Diagnosis... 71K€ Cerrado

IBDIMAGE Disruptive fluorescent technologies for inflammatory bowel d... 150K€ Cerrado

NEUROGUT Targeted insula stimulations as treatment for autoimmune dis... 150K€ Cerrado

PID2021-123918OB-I00 ESTUDIO DE LA HETEROGENIDAD EN LA ENFERMEDAD INFLAMATORIA IN... 339K€ Cerrado

Líder del proyecto

TECHNISCHE UNIVERSITEIT DELFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Inflammatory Bowel diseases (IBDs) constitute on of the largest healthcare problems in the Western World, affecting over 1 million European citizens alone, 700,000 of whom suffer from Crohn's disease.Grading of Crohn's disease severity is important to determine treatment strategy and to quantify the response to treatment. Colonoscopy in combination with the assessment of biopsy samples is considered the reference standard for diagnosis of all IBD. However, the procedure is invasive and requires extensive bowel preparation, which is considered very burdensome by most patients. Moreover, it only gives information on superficial abnormalities.The VIGOR++ project aims to create a multiscale, personalised GI tract model, which facilitates improved detection of Crohn's disease and drives an accurate index of Crohn's disease severity.VIGOR++ will acquire laboratory, MRI, colonoscopy and microscopy (histopathology) data in order to develop the targeted ICT tools. A novel integration of existing models is employed to predict features on the molecular to cellular scale (microscopy/colonoscopy) from descriptive properties at the organ to patient scales (MRI/laboratory). Effectively, this would render the standard methods (colonoscopy/biopsy) superfluous.The tools sustain early diagnosis, improved therapy planning and a better quality of life for patients. The clinical benefit is demonstrated by an assessment of the tools' performance to predict Crohn's disease status. Moreover, a preliminary study will be performed in which the effect of therapy is evaluated using the VIGOR++ tools.The consortium harbours leading groups in abdominal radiology, medical image analysis, modelling, scientific visualization, gastroenterology and commercial diffusion. Importantly, it has solid plans for the commercialisation of the generated innovations. Notably, the ICT tools are developed in a clinically used environment, 3Dnet™ Suite, so that they can be readily commercialized.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores